Prellis Biologics Stock

prellisbio.comHealthcare / BioTech & PharmaFounded: 2016

Prellis Biologics, is a San francisco, California based 3-D printing company specializing in organ and tissue engineering. Prellis Biologics focuses on research and development that aims to provide solutions within the transplatation and donation healthcare industry, through holographic bioprinting. Additionally, Prellis Biologics researches healthcare solutions for cancerous diseases such as tumor, through its proprietary, 3-D technology.

Register To Buy and Sell Shares

For more details on financing and valuation for Prellis Biologics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Prellis Biologics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Prellis Biologics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Mike Nohaile
Chief Executive Officer
Melanie Matheu, PhD
Founder & Chief Technology Officer
kevin Chapman, PhD
Chief Scientific Officer
Yelda Kaya, MBBS, LLC, MBA
Chief Business Officer
Andrew McFarland, PhD
Senior Vice President of Technology
Erin Stephens, PhD
Vice President of Tissue Engineering and Antibody Discovery

Board Members

James Rothman
Cell Biologist
Lei Meng
Michael Marks
Celesta Capital

Frequently Asked Questions About Prellis Biologics’ Stock

Can you buy Prellis Biologics’ stock?
Prellis Biologics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Prellis Biologics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Prellis Biologics’ stock?
Yes, you can sell stock of a private company like Prellis Biologics. Forge can help you sell your Prellis Biologics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Prellis Biologics’ stock price?
Prellis Biologics is a privately held company and therefore does not have a public stock price. However, you may access Prellis Biologics’ private market stock price with Forge Data.
What is Prellis Biologics’ stock ticker symbol?
Prellis Biologics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Prellis Biologics Raises $35M in Series C Funding
Prellis Biologics, a San Francisco, CA-based biotherapeutics company, raised $35M in Series C funding
Updated on: May 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.